Clinical trial readout dates for Vera Therapeutics Inc., compiled from
ClinicalTrials.gov, alongside the SEC filings where results are announced.
The next expected readout is November 2027.
Next readoutNovember 2027in ~12 months
Upcoming readouts2none in Phase 3
Market cap$2.5B
Cash & investments$384M~4 quarters at last loss rate
IgA Nephropathy (IgAN); Renal and Urinary Disorders · NCT06674577
May 2031
Enrolling
Cash position
Vera Therapeutics Inc. reported $384M in cash, cash equivalents and marketable securities at Sep 30, 2026 (10-Q filed 2026-11-05). Its net loss for that quarter was $94M; at that rate the cash would last about 4 quarters. This is a rough guide: net loss includes non-cash items such as stock compensation, and does not count money the company may raise, so its own runway guidance can differ.
Recent SEC filings
8-KResults of Operations — earnings, may carry pipeline updates